Clinical Trials in Nashville

Showing 2121-2140 of 9,711 trials

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

NCT06125743

The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.

Lymphedema of the Head and Neck

Abramson Cancer Center at Penn Medicine204 participantsStarted Mar 2024

Philadelphia, Pennsylvania, United States • Nashville, Tennessee, United States

Active Not RecruitingPhase 3< 1 mile

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

NCT05239728

The purpose of this study is to assess the efficacy and safety of oral belzutifan (MK-6482) plus intravenous (IV) pembrolizumab (MK-3475) compared to placebo plus pembrolizumab, in the adjuvant treatment of Clear Cell Renal Cell Carcinoma (ccRCC) post nephrectomy. The primary study hypothesis is that belzutifan plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS).

Carcinoma, Renal Cell

Merck Sharp & Dohme LLC1,800 participantsStarted Mar 2022

Phoenix, Arizona, United States • Duarte, California, United States • La Jolla, California, United States +282 more locations

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Find Trials by Condition in Nashville

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Expanded Access of Sotorasib

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment (SUMMIT)

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma